Diabetic Kidney Disease
Conditions
Interventions
Experimental group:Oral administration of Yishen Tongluo Formula aqueous solution
Control group:Oral administration of Yishen Tongluo Formula Simulant
Sponsors
The First Affiliated Hospital of Henan University of Chinese Medicine
Eligibility
Sex/Gender
All
Age
18 Years to 75 Years
Inclusion criteria
Inclusion criteria: 1: Meets the diagnostic criteria for DKD (Phase 3) 2: Traditional Chinese Medicine syndrome differentiation meets the criteria for liver and kidney yin deficiency combined with blood stasis syndrome 3: Age 18-75 years old 4: Voluntarily accept treatment and sign an informed consent form
Exclusion criteria
Exclusion criteria: 1: Patients with acute complications of diabetes and urinary tract infection within one month 2: Patients with severe primary diseases such as liver kidney and hematopoietic system combined 3: Patients with severe cardiovascular and cerebrovascular diseases 4: Pregnant or lactating women or those preparing for pregnancy 5: Individuals with mental illness or cognitive impairment 6: Individuals with allergic constitution or allergic to the composition of the drug in this preparation 7: Participants in other clinical trials within one month prior to enrollment
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Ratio of urinary microalbumin to urinary creatinine; | — |
Secondary
| Measure | Time frame |
|---|---|
| Traditional Chinese Medicine Symptom Score;Tumor necrosis factor a;2-hour Postprandial Blood Glucose;Cystatin C;High-density lipoprotein cholesterol;Interleukin-6;Serum Total Cholesterol;EuroQol five dimensions questionnaire;estimated glomerular filtration rate;Triglyceride;Serum uric acid;Diabetes quality of life measure;Blood urea nitrogen;Interleukin-1;Fasting Blood Glucose;Serum creatinine;Glycosylated hemoglobin;C-reactive protein;Low-density lipoprotein cholesterol; | — |
Countries
China
Contacts
Public ContactJiangyan Xu
Henan University of Chinese Medicine
Outcome results
None listed